A 4-year longitudinal study of gray matter atrophy in multiple sclerosis patients

被引:0
|
作者
Fisher, Elizabeth
Lee, Jar-Chi
Nakamura, Kunio
Rudick, Richard
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A242 / A243
页数:2
相关论文
共 50 条
  • [21] Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study
    Bergsland, Niels
    Horakova, Dana
    Dwyer, Michael G.
    Uher, Tomas
    Vaneckova, Manuela
    Tyblova, Michaela
    Seidl, Zdenek
    Krasensky, Jan
    Havrdova, Eva
    Zivadinov, Robert
    NEUROIMAGE-CLINICAL, 2018, 17 : 444 - 451
  • [22] Impact of Focal White Matter Damage on Localized Subcortical Gray Matter Atrophy in Multiple Sclerosis: A 5-Year Study
    Fuchs, T. A.
    Carolus, K.
    Benedict, R. H. B.
    Bergsland, N.
    Ramasamy, D.
    Jakimovski, D.
    Weinstock-Guttman, B.
    Kuceyeski, A.
    Zivadinov, R.
    Dwyer, M. G.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2018, 39 (08) : 1480 - 1486
  • [23] Relationship between apathy and cognitive dysfunctions in multiple sclerosis: A 4-year prospective longitudinal study
    Raimo, Simona
    Trojano, Luigi
    Gaita, Mariachiara
    D'Onofrio, Florindo
    Spitaleri, Daniele
    Santangelo, Gabriella
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 63
  • [24] Intrathecal inflammatory profile predicts disease course in multiple sclerosis: a 4-year longitudinal study
    Calabrese, M.
    Pisani, A.
    Ziccardi, S.
    Pizzini, F. B.
    Bajrami, A.
    Tamanti, A.
    Guandalini, M.
    Bonomi, S.
    Rossi, S.
    Mazziotti, V.
    Montemezzi, S.
    Zuco, C.
    Crescenzo, F.
    Marastoni, D.
    Pitteri, M.
    Scalfari, A.
    Romualdi, C.
    Reynolds, R.
    Magliozzi, R.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 274 - 274
  • [25] Multimodal magnetic resonance longitudinal study on the deep gray matter in multiple sclerosis patients with teriflunomide
    Xu, Yuhui
    Wei, Yiqiu
    Shi, Zhuowei
    Yin, Feiyue
    Zhu, Qiyuan
    Luo, Dan
    Tang, Yang
    Wang, Huajiao
    Yan, Zichun
    Feng, Jinzhou
    Li, Yongmei
    JOURNAL OF NEUROIMMUNOLOGY, 2024, 396
  • [26] A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis
    Khalid, Fariha
    Tauhid, Shahamat
    Chua, Alicia S.
    Healy, Brian C.
    Stankiewicz, James M.
    Weiner, Howard L.
    Bakshi, Rohit
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2017, 127 (05) : 396 - 403
  • [27] Disability and gray matter atrophy in multiple sclerosis patients with no evidence of disease activity: a one-year follow-up study
    Nygaard, G.
    Celius, E. G.
    Benavent, S. A. D. R.
    Sowa, P.
    Gustavsen, M. W.
    Fjell, A. M.
    Landro, N. I.
    Walhovd, K. B.
    Harbo, H. F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 253 - 253
  • [28] The effect of fingolimod on cerebral gray matter atrophy in multiple sclerosis
    Yousuf, F.
    Dupuy, S.
    Tauhid, S.
    Chu, R.
    Kim, G.
    Tummala, S.
    Chitnis, T.
    Healy, B. C.
    Bakshi, R.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 549 - 549
  • [29] A longitudinal study of deep grey matter atrophy in patients with multiple sclerosis. A case control study
    Zivadinov, R.
    Ramasamy, D.
    Havrdova, E.
    Bergsland, N.
    Seidl, Z.
    Abdelrahman, N.
    Dwyer, M. G.
    Vaneckova, M.
    Horakova, D.
    MULTIPLE SCLEROSIS JOURNAL, 2007, 13 : S182 - S182
  • [30] What Causes Deep Gray Matter Atrophy in Multiple Sclerosis?
    Schoonheim, M. M.
    Geurts, J. J. G.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2019, 40 (01) : 107 - 108